| 7:00 - 8:00 AM | Continental Breakfast |
SESSION 9
Use of the Blood BeLPT
Moderator: Milton D. Rossman, MD
| 8:00 - 8:15 AM | Should the BeLPT be Used to Screen for Beryllium Disease
Con: Mark R. Cullen, MD
| | 8:15 - 8:30 AM | Pro: Timothy K. Takaro, MD, MPH, MS | | 8:30 - 8:45 AM | Questions and Answers | | 8:45 - 9:00 AM | What Test Results Define Sensitization
Dan Middleton, MD, MPH
| | 9:00 - 9:20 AM | New Tests for Beryllium Sensitization
Andrew P. Fontenot, MD | | 9:20 - 9:50 AM | Ethical Issues in Testing for Beryllium Sensitization and Disease
Kenneth Silver, PhD
| | 9:50 - 10:05 AM | Abstract Presentation: Reproducibility Study of the Beryllium Lymphocyte Proliferation Test (BeLPT)
Pauline Brousseau, PhD
(Not CME Certified)
| | 10:05 - 10:20 AM | BREAK |
SESSION 10
Current Status of Guideline Development
Moderator: Chantal Dion, PhD
| 10:20 - 10:35 AM | The OSHA Rulemaking Process
Amanda Edens | | 10:35 - 10:50 AM | The ACGIH TLV Process
Terry Gordon, PhD, MS | | 10:50 - 11:05 AM | Beryllium in the Work Place: Québec's Plan
Chantal Dion, PhD
| | 11:05 - 11:20 AM | Beryllium Surveillance Program in Switzerland
Jérome Lavoué, PhD
| | 11:20 - 11:35 AM | Beryllium Health Effects: Research Directions From the Perspective of an Occupational Epidemiologist
Donna L. Cragle, PhD | | 11:35 - 11:50 PM | Status of the ATS Statement
Milton D. Rossman, MD
| | 11:50 - 12:05 PM | Conference Summary, Evaluation
| | 12:05 PM | ADJOURNMENT |
|
